GLABF Stock Price, Chart, Stats & News

Gemina Laboratories Ltd.
Save
Gemina Laboratories Ltd. (GLABF) does not currently pay a dividend.
3.83M
Market cap
–
Current P/E
–
Forward P/E
GLABF chart
1M
3M
1Y
5Y
Loading chart...
About
Health care
Sector
Biotechnology
Industry
Gemina Laboratories Ltd. is a Canadian biotechnology enterprise primarily focused on the investigation, creation, and commercialization of in vitro diagnostic solutions. The firm's innovation extends to developing unique surface functionalization chemistries specifically designed for the identification of pathogens and various biological markers. A significant ongoing project is the POC Antigen COVID test, a rapid, point-of-care lateral flow assay strip intended to determine active COVID-19 infections.
Similar securities
Based on sector and market capitalization
Report issue




